Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxford AstraZeneca Vaccine in Zagazig University HCWs
NCT04756271Phase 3Completed
- Sponsor
- Zagazig University
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by Zagazig University. Started Feb 2021; status: completed.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04756271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04756271.